About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNCT03662009

Multi-limb Dual-task Control in Parkinson's Disease

People with Parkinson disease commonly experience difficulty driving, which requires the arms and legs to do different tasks simultaneously. Driving difficulties can lead to isolation, depression, los...

Lead sponsor: A.T. Still University of Health Sciences•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

A.T. Still University of Health Sciences

Collaborators

National Institute of Neurological Disorders and Stroke (NINDS)
University of Idaho
Mayo Clinic

Age

21 - No limit years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•have a clinical diagnosis of mild to moderate idiopathic PD (Hoehn \& Yahr stages 1-3),
•hold a valid driver's license and drive at least once a week, and
•be capable of providing informed consent and complying with study procedures. Control group participants will be healthy, neurologically intact individuals, age-matched to within 2 years of the PD subjects.

Exclusion Criteria

•impaired global cognition (i.e., a score of \< 20 on the Montreal Cognitive Assessment (MoCA) screening tool)
•sensory loss in the lower limb as assessed by clinical test of vibration perception at the ankle,
•orthopedic, visual, or neurological conditions that would prevent performance of the experimental tasks,
•inability to complete and pass the assessment testing,
•history of neurological illness such as head trauma, previous stroke, epilepsy, demyelinating disease, or
•complicating medical problems such as diabetes.

Related studies

Striatal and Extra-Striatal Cholinergic Terminal Density in LRRK2-PD Mutation

NCT07642908 · Parkinson Disease

RECRUITINGPhase 2

A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease

NCT06680830 · Parkinson Disease, Parkinson, and more

Cognitive Decline Following Deep Brain Stimulation

NCT05822388 · Parkinson Disease, Movement Disorders

Real-World Study of Foslevodopa/Foscarbidopa to Assess Quality of Life Outcomes in Adult Participants With Advanced Parkinson Disease

NCT06965374 · Parkinson Disease

Patient-Specific 3D Action Observation Training in Parkinson's Disease

NCT07250672 · Parkinson Disease, Virtual Reality, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 7, 2022Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment60

Start dateSep 2017

Last updatedFeb 7, 2022

Condition

Parkinson Disease

Locations shown

A.T. Still University Arizona School of Health Sciences

Mesa, Arizona

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 7, 2022Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions